Literature DB >> 29503381

The National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged 2010 (NIPPON DATA2010): Objectives, Design, and Population Characteristics.

Aya Kadota1,2, Nagako Okuda3, Takayoshi Ohkubo4, Tomonori Okamura5, Nobuo Nishi6, Hirotsugu Ueshima1,2, Akira Okayama7, Katsuyuki Miura1,2.   

Abstract

BACKGROUND: The structure and risk factors for cardiovascular diseases (CVD) in Japan may change because lifestyle, particularly nutrition, socioeconomic status, and medical care, which affect CVD, may markedly change over time. Therefore, a new prospective cohort study on a representative general Japanese population based on national surveys is required.
METHODS: In November 2010, the baseline survey of the National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged 2010 (NIPPON DATA2010) was performed with the National Health and Nutrition Survey of Japan (NHNS2010) in 300 randomly selected districts throughout Japan. The survey included a questionnaire, electrocardiogram, urinalysis, and blood biomarkers added to the NHNS2010 examinations. Physical measurements, blood biomarkers, and dietary data were also obtained in NHNS2010. Socioeconomic factors were obtained by merging with the Comprehensive Survey of Living Conditions 2010 (CSLC2010) dataset. Participants are followed annually for the incidence of diabetes mellitus, CVD events (acute coronary events, heart failure, atrial fibrillation, and stroke), and cause-specific mortality. The activities of daily living are followed every 5 years.
RESULTS: A total of 2,898 individuals aged 20 years or older agreed to participate in the baseline survey of NIPPON DATA2010. The participation rate was 74.6%. Of these, data from NHNS2010 was merged for 2,891 participants (1,236 men and 1,655 women). The data of 2,807 participants were also merged with CSLC2010 data.
CONCLUSIONS: We established NIPPON DATA2010 as a cohort study on a representative general Japanese population that covers all of Japan.

Entities:  

Keywords:  Japanese; NIPPON DATA2010; cardiovascular diseases; cohort study; study profiles

Mesh:

Year:  2018        PMID: 29503381      PMCID: PMC5825689          DOI: 10.2188/jea.JE20170240

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


BACKGROUND AND PURPOSE

Cardiovascular disease (CVD) is the leading cause of death worldwide and adversely affects healthy life expectancy.[1],[2] The National Survey of Circulatory Disorders (NSCD) has been conducted in Japan every decade since the 1960s by the Ministry of Health and Welfare in order to assess the current status of CVD among Japanese adults for the development of future preventive measures.[3] The study group of the National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged (NIPPON DATA) conducted long-term cohort studies on participants of the 3rd NSCD in 1980 and 4th NSCD in 1990, when the Japanese economy was growing, named NIPPON DATA80 and NIPPON DATA90.[4]–[8] Many findings from our studies were utilized in preventive measures, such as the National Health Promotion Movement in the Twenty-first Century (Health Japan 21) and Health Japan 21 (the second term).[9],[10] The structure of diseases in Japan may have subsequently changed because of the rapid aging of its population, together with changes in lifestyle, medical care, and socioeconomic status (SES) based on the low-growth economy.[11],[12] Under these conditions, the expansion of health inequality has been reported.[13] Although the social determinants of health inequality need to be identified in order to prompt political action, the effects of SES on health have not yet been fully investigated in Japan.[14],[15] Therefore, a new cohort study on a representative general Japanese population based on national surveys that cover all of Japan with standardized methods and enable assessments of health-related factors from multiple aspects, including SES, is required. We herein describe the objectives, design, and characteristics of a new cohort study, NIPPON DATA2010, which started in 2010 with the purpose of monitoring and revealing factors related to CVD in a recent Japanese population.

METHODS

Study participants

NIPPON DATA2010 was established as a prospective cohort study of participants of the National Health and Nutrition Survey of Japan in 2010 (NHNS2010) and Comprehensive Survey of Living Conditions in 2010 (CSLC2010), which were conducted by the Ministry of Health, Labour and Welfare of Japan (Figure 1).
Figure 1.

Study population of NIPPON DATA2010. The 5,510 CEAs selected for CSLC2010 were divided into 11,000 unit blocks consisting of 20–30 households each for NHNS2010 sampling. CEA, census enumeration area; CSLC2010, Comprehensive Survey of Living Conditions 2010; NHNS2010, National Health and Nutrition Survey 2010.

CSLC2010

In June 2010, CSLC was conducted in order to survey national living conditions, such as health, medical care, welfare, pension, income, and related factors.[16] Sampling was based on the national population census enumeration area (CEA), which covered all of Japan. Each CEA consisted of approximately 50 households. In the 2010 survey, approximately 290,000 households from 5,510 randomly selected CEAs were sampled for the Household Survey and Health Status Survey. The response rate was 79.4%. Among these CEAs, the Saving Survey and Income Survey covered 2,500 randomly selected unit blocks; each unit block consisted of 20–30 households, approximately half of which were in the CEA. The Nursing Care Survey also covered 2,500 unit blocks that partially overlapped. Detailed information on CSLC was described elsewhere.[16]

NHNS2010

Among the 5,510 CEAs (11,000 unit blocks) for CSLC2010, 300 unit blocks from throughout Japan were randomly selected for NHNS2010. All household members who resided in the blocks and participated in CSLC2010 were announced to participate in NHNS2010 in November 2010. A total of 8,815 residents aged 1 year and older from 3,684 households participated in the survey (Figure 1). The participation rate by households was 68.8%. Adult participants aged 20 years or older were also asked to take lifestyle questionnaires and blood examinations for NHNS2010, in addition to the dietary survey and physical examination, with 7,881 (2,672 men and 4,209 women) taking the lifestyle questionnaire and 3,873 (1,598 men and 2,275 women) taking the blood examination for NHNS2010. Details of NHNS2010 were described elsewhere.[17],[18]

NIPPON DATA2010

The baseline survey for NIPPON DATA2010 was performed simultaneously with NHNS2010 in November 2010.[19],[20] Trained staff explained the aim and methods of NIPPON DATA2010 to the 3,873 participants aged 20 years or older who underwent the blood examination for NHNS2010 at the NHNS2010 places such as public health centers. A total of 2,898 participants (1,239 men and 1,659 women; participant rate, 74.6%) agreed to participate in the baseline survey for NIPPON DATA2010. Staff obtained written informed consent from all participants before enrollment. The Institutional Review Board of Shiga University of Medical Science (No. 22-29, 2010) approved this study. Of the 2,898 participants, 7 were excluded because it was not possible to merge data from NHNS2010. Thus, the remaining 2,891 participants (1,236 men and 1,655 women) provided baseline data for NIPPON DATA2010. In the analysis of socioeconomic factors, 2,807 participants who were also merged to CSLC2010 were listed. Regarding the follow-up survey, 2,732 participants (1,170 men and 1,562 women) agreed to be included in the study.

Measures

The measures of NIPPON DATA2010 were composed of three parts: NHNS2010, CSLC2010, and specific measures in NIPPON DATA2010. The outline of the integrated dataset, variables, and their original survey are listed in Table 1. Health professionals for NHNS2010 and trained staff for NIPPON DATA2010 collected information on smoking, alcohol consumption, and medical history. Lifestyle-related factors, including knowledge of CVD risk factors, were asked using self-administered questionnaires. Regarding physical activity, the time (hours) spent at each activity level was also asked: heavy activity, moderate activity, slight activity, watching television, other sedentary time, and no activity (sleeping). The interviewer then ensured that the total time added up to 24 hours, and the physical activity index was calculated by multiplying the time and corresponding weighting factor estimated in the Framingham study.[21] The activities of daily living (ADL) were also asked for five aspects: eating, using the toilet, dressing, bathing or taking a shower, and walking, with answers of “independent” or “need assistance”.[22] Information on instrumental activities of daily living (IADL), intellectual activities, and social roles was also obtained based on the Tokyo Metropolitan Institute of Gerontology Index of Competence.[23] Socioeconomic factors, such as household composition and monthly household expenditure, were obtained from CSLC2010 with the permission of the Ministry of Health, Labour and Welfare. Equivalent household expenditure (EHE) was estimated using the following formula: EHE = monthly household expenditure/square root of the number of household members. Information about medical insurance and pension was also obtained from CSLC2010. The dietary intake data of NHNS2010, which was assessed by 1-day semi-weighted household dietary records, were also obtained with the allowance of the Ministry of Health, Labour and Welfare. The detailed procedure for the dietary survey was described elsewhere.[17],[18]
Table 1.

Outline of the integrated NIPPON DATA2010 dataset, variables, and their original surveys

NIPPON DATA2010 specific data (November 2010)
  History and treatment of hypertension, diabetes mellitus, and dyslipidemia
  Activity of daily living
  Educational attainment
  Questions for depressive mood (K6)
  Knowledge of symptoms/implications of stroke, CHD, and CVD risk factors.
  Normal physical activity level (breakdown of 24 hr by Mets categories)
  Menopausal status (for women)
  Biomarkers (BNP, high sensitivity CRP, urinary Cre, Na, K, and albumin)
  Electrocardiogram reading by Minnesota codes
National Health and Nutrition Survey 2010 (November 2010)
  Anthropometric measurements
  Biomarkers (blood cell counts and blood biochemistry)
  Blood pressure
  Lifestyle questionnaire
   History of stroke, CHD, and renal disease
   Engaged in lifestyle modifications
   Dental health habits
   Smoking habit (including passive smoking)
   Drinking habit
   History of CVD risk factors
  Results from the dietary survey (one-day semi-weighing dietary record)
   Food intake (99 foods, per day)
   Nutrient intake (42 nutrients, per day)
Comprehensive Survey of Living Conditions 2010 (June 2010)
 Household survey
  Household composition
   Number of household members, marital status, offspring,multigenerational household
  Housing (rented/owned, detached/apartment)
  Household expenditure
  Medical insurance, public pension
  Occupation (type of job, size of company)
 Health status survey
  Subjective symptoms (43 symptoms)
  Medical treatment (39 diseases)
  Physical impairments affecting daily life
  Subjective sense of well-being
  Questions for depressive mood (K6)
  Physical check-up
  Cancer screening

CHD, coronary heart disease; CVD, cardiovascular disease; BNP, brain natriuretic peptide; CRP, C-reactive protein.

CHD, coronary heart disease; CVD, cardiovascular disease; BNP, brain natriuretic peptide; CRP, C-reactive protein. Physical measurements were obtained by trained health professionals. They measured blood pressure in duplicate using a standard mercury sphygmomanometer on the right arm of seated participants after 5 minutes of rest. A 12-lead resting electrocardiogram (ECG) was also recorded. Each ECG record was manually read according to the Minnesota codes by two trained researchers independently.[24],[25] When the coding results mismatched, the central committee of ECG reading adjudicated the codes. In the baseline survey, casual blood samples were obtained. Serum was separated and centrifuged soon after blood coagulation. Plasma samples were collected into siliconized tubes containing sodium fluoride and shipped to a central laboratory (SRL, Tokyo, Japan) for blood measurements. Serum triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were measured using enzymatic methods, which have been standardized by the Lipid Standardization Program of the US Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network (CDC/CRMLN).[26] Blood glucose was measured using hexokinase UV methods, and hemoglobin A1c (HbA1c) was measured using latex agglutination inhibition assays with the standardized method of the Japan Diabetes Society (JDS). HbA1c values were converted into the National Glycohemoglobin Standardization Program (NGSP) value using the following formula: HbA1c (NGSP) (%) = 1.02 × HbA1c (JDS) (%) + 0.25.[27] Serum creatinine was measured enzymatically. High-sensitivity C-reactive protein (CRP) was measured using nephelometry methods, and brain natriuretic peptide (BNP) was measured via CLEIA using MI02 Shionogi BNP (Shionogi Co. Ltd., Osaka, Japan). Information on blood chemistry data measurements and their performance was described elsewhere.[26] Spot urine samples were also collected and shipped to the same laboratory at which blood measurements were examined. Urine creatinine was measured enzymatically. Urine sodium and potassium were measured using selective ion electrode methods. Urine albumin and protein were measured using immuno-nephelometry and pyrogallol red methods.

Follow-up

As the first step, the incidence of stroke, heart disease, and diabetes mellitus is surveyed annually from participants using the self-administered questionnaire via mail or telephone interviews. In the second step, when the incidence of these diseases is reported by participants or their family members, detailed medical records will be referred to the hospitals from the central office of the NIPPON DATA Research Group. The incidence of these diseases will then be assessed at the event adjudication committee of the study group. Information on medication for hypertension, dyslipidemia, and diabetes mellitus is also collected annually. The ADL and IADL survey is also performed every 5 years using the self-administered questionnaire. Participants who die during the follow-up are confirmed by computer matching with the National Vital Statistics database, using area, sex, date of birth, and date of death as key codes, with the permission of the Management and Coordination Agency of the Government of Japan. The underlying causes of death in the National Vital Statistics database are coded according to the 10th International Classification of Disease (ICD-10). Details of these classifications have been described elsewhere.[28]

Main outcome measures

The study main outcome measures are listed in Table 2. All diagnoses will be based on medical records obtained from the hospitals. Each case is independently diagnosed by two trained medical doctors. When their diagnoses are mismatched, the committee adjudicates. The diagnostic criteria of main outcome events are described as follows.
Table 2.

Main outcome measures: NIPPON DATA2010

IncidenceStroke
  Ischemic stroke
  Hemorrhagic stroke
  Subarachnoid hemorrhage
  Unclassified
 Myocardial infarction
 Invasive treatment for coronary heart disease
 Arrhythmia
  Atrial fibrillation
  Sick sinus syndrome
  Atrioventricular block
  others
 Heart failure
 Diabetes mellitus
MedicationHypertension
 Dyslipidemia
 Diabetes mellitus
Activities of daily living (ADL)
Instrumental activities of daily living (IADL)

Heart disease

Myocardial infarction is diagnosed using the modified MONICA criteria or third universal definition of myocardial infarction by ESC/ACCF/AHA/WHF.[29],[30] Invasive procedures for coronary arteries, such as coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), are also considered as outcome events. Heart failure is diagnosed according to the Framingham Heart Study criteria.[31] Researchers diagnose the case, taking into account symptoms and laboratory tests when the components of criteria are not fully collected. The acute exacerbation of chronic heart failure is also considered to be an outcome event when the case meets the Framingham criteria and requires hospitalization. Regarding arrhythmia, atrial fibrillation is diagnosed based on ECG findings. Sick sinus syndrome, atrioventricular block, and other arrhythmias are considered to be outcome events when the participant requires the insertion of a cardiac pacemaker.

Stroke

Stroke is diagnosed with neurological symptoms that continue for 24 hours or longer.[32] Secondary stroke due to injuries, leukemia, and tumors is excluded from outcome events. The stroke subtype is diagnosed based on imaging findings.

Diabetes mellitus

Diabetes mellitus is diagnosed according to the modified criteria of the JDS as follows: 1) fasting blood glucose 126 mg/dL or higher, 2) casual blood glucose 200 mg/dL or higher, 3) HbA1c 6.5% or higher, and/or 4) medication for diabetes mellitus.[33] A case that meets any one of these criterion items is considered to be an incident case of diabetes mellitus.

Baseline descriptive statistics

The baseline characteristics of participants are shown in Table 3. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; HbA1c, hemoglobin A1c. Data were expressed as mean (standard deviation [SD]) for continuous variables, except triglycerides and the physical activity index (median [25%–75%]), and in % for dichotomous variables. P values for differences between men and women were estimated by t-tests for continuous variables, Mann Whitney tests for triglycerides and the physical activity index, and chi-squared tests for dichotomous variables. Co-morbidities were defined as follows: Hypertension (SBP 140 mm Hg and higher and/or DBP 90 mm Hg and higher and/or on medication), diabetes mellitus (fasting blood glucose 126 mg/dL and higher and/or non-fasting blood glucose 200 mg/dL and higher and/or HbA1c 6.5% and higher and/or on medication. Samples obtained more than 8 hours after the last meal were considered to be fasting blood samples), hypercholesterolemia (LDL 140 mg/dL and higher and/or medication), hypertriglyceridemia (TG 150 mg/dL and higher and/or on medication), low HDL cholesterolemia (HDL-cholesterol less than 40 mg/dL), dyslipidemia (hypercholesterolemia and/or hypertriglyceridemia and/or low HDL cholesterolemia). A history of stroke and myocardial infarction was based on self-reports. JPY, Japanese Yen. Data were expressed as mean (standard deviation [SD]) for age, as a median (25%–75%) for equivalent household expenditure (EHE), and in % for dichotomous variables. P values for differences between men and women were estimated by t-tests for continuous variables, Mann Whitney tests for EHE, and chi-squared tests for dichotomous variables. Working status was categorized as follows: unemployed (unemployed, full-time homekeeper or retiree), self-employed (self-employed or family employee), indefinite-term employee (exective, indefinite-term employee or limited-term employee with 1 year and longer), limited-term employee (limited-term employee shorter than 1year). EHE was estimated using the following formula: EHE = monthly household expenditure/square root of the number of household members.

Strengths and limitations

We established NIPPON DATA2010 as a cohort study on a representative general Japanese population. Because the extraction method of study participants and ECG coding method were the same as in the NSCD, which were performed recently in 2000, we could consider NIPPON DATA2010 as the successor survey of NSCD. The study obtained not only physical measures, but also lifestyle factors, diet (NHNS2010), and socioeconomic factors (CSLC2010), and data collection and measurement methods were highly standardized.[26] Thus, we will provide important information from multiple aspects for future strategies for CVD prevention and management in Japan. The integration method we adopted to use data from CSLC2010 may be applicable to NIPPON DATA80 and NIPPON DATA90, which will enable us to investigate the effects of changes in SES on health inequality from 1980. Several limitations need to be noted for this study. The reporting bias for the measures obtained using the self-administered questionnaire, including data from NHNS and CSLC, may remain. Furthermore, the low response rates of NHNS may decrease the representativeness of this study. Nishi et al reported that the individual response rates of NHNS’s blood tests between 2003 and 2007 were between 31.6% and 39.3% via linking of CSLC and NHNS.[34],[35] They also showed that socio-demographic factors and lifestyle, such as being active, were related to cooperation for blood testing in NHNS. However, due to the lack of other cohort studies based on recent national surveys using a cluster random sampling design in Japan, NIPPON DATA2010 is considered to be the best available cohort that represents a recent Japanese population from all over Japan.
Table 3A.

Physical characteristics of participants: NIPPON DATA2010 baseline (1,236 men and 1,655 women)

 MenWomenP value
Number1,2361,655 
Age, years60.0 (15.6)58.0 (16.1)0.001
BMI, kg/m223.9 (3.2)22.7 (3.6)<0.001
Systolic blood pressure, mm Hg136.4 (18.0)130.0 (20.0)<0.001
Diastolic blood pressure, mm Hg82.1 (10.8)77.2 (10.8)<0.001
Total cholesterol, mg/dL201.5 (34.2)208.7 (36.3)<0.001
LDL cholesterol, mg/dL118 (30.0)119 (32.2)0.208
HDL cholesterol, mg/dL57 (14.9)66 (15.1)<0.001
Triglycerides, mg/dL128 (90–190)98 (67–142)<0.001
HbA1c (NGSP), %5.9 (0.9)5.8 (0.7)0.002
Co-morbidity, %   
 Hypertension58.242.5<0.001
 Diabetes mellitus15.19.1<0.001
 Hypercholesterolemia32.737.90.004
 Hypertriglyceridemia41.924.7<0.001
 Low HDL cholesterolemia11.61.8<0.001
 Dyslipidemia59.148.9<0.001
 Stroke5.32.80.001
 Myocardial infarction3.20.7<0.001
Medication, %   
 Hypertension31.724.6<0.001
 Diabetes mellitus8.75.2<0.001
 Hypercholesterolemia12.015.30.011
 Hypertriglyceridemia5.22.2<0.001
Physical activity index34.5 (30.4–40.5)36.5 (32.9–40.3)<0.001
Smoking, %   
 Never35.087.8<0.001
 Past37.65.9 
 Current27.46.3 
Drinking, %   
 Never25.563.0<0.001
 Past3.11.4 
 Current71.435.6 

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; HbA1c, hemoglobin A1c.

Data were expressed as mean (standard deviation [SD]) for continuous variables, except triglycerides and the physical activity index (median [25%–75%]), and in % for dichotomous variables. P values for differences between men and women were estimated by t-tests for continuous variables, Mann Whitney tests for triglycerides and the physical activity index, and chi-squared tests for dichotomous variables.

Co-morbidities were defined as follows: Hypertension (SBP 140 mm Hg and higher and/or DBP 90 mm Hg and higher and/or on medication), diabetes mellitus (fasting blood glucose 126 mg/dL and higher and/or non-fasting blood glucose 200 mg/dL and higher and/or HbA1c 6.5% and higher and/or on medication. Samples obtained more than 8 hours after the last meal were considered to be fasting blood samples), hypercholesterolemia (LDL 140 mg/dL and higher and/or medication), hypertriglyceridemia (TG 150 mg/dL and higher and/or on medication), low HDL cholesterolemia (HDL-cholesterol less than 40 mg/dL), dyslipidemia (hypercholesterolemia and/or hypertriglyceridemia and/or low HDL cholesterolemia). A history of stroke and myocardial infarction was based on self-reports.

Table 3B.

Socioeconomic characteristics of participants: NIPPON DATA2010 baseline

 MenWomenP values
Number1,2361,655 
Age, years60.0 (15.6)58.0 (16.1)0.001
Length of education, %   
 >13 years32.330.30.145
 10–12 years41.945.6 
 <10 years25.824.1 
Marital Status, %   
 Married81.172.7<0.001
 Single18.927.3 
Living Status, %   
 Living with others91870.004
 Living alone913 
Working status, %   
 Unemployed37.056.3<0.001
 Employed63.043.7 
  Self-employed29.823.1<0.001
  Indefinite-term employee60.455.9 
  Limited-term employee7.517.7 
  Others2.33.2 
Health Insurance, %   
 National health insurance40.938.00.088
 Employees’ health insurance41.245.1 
 Medical care system for the elderlyin the later stages of life16.115.2 
 Others1.20.7 
 Unknown0.61.0 
Houseowner, %81.481.40.998
Equivalent household expenditure,104 JPY12.7 (8.9–17.5)13.3 (9.0–17.5)0.503
Household income, JPY, %   
 <2,000,00018.021.00.101
 2,000,000–6,000,00058.254.3 
 >6,000,00019.919.8 
 Unknown3.94.9 

JPY, Japanese Yen.

Data were expressed as mean (standard deviation [SD]) for age, as a median (25%–75%) for equivalent household expenditure (EHE), and in % for dichotomous variables. P values for differences between men and women were estimated by t-tests for continuous variables, Mann Whitney tests for EHE, and chi-squared tests for dichotomous variables.

Working status was categorized as follows: unemployed (unemployed, full-time homekeeper or retiree), self-employed (self-employed or family employee), indefinite-term employee (exective, indefinite-term employee or limited-term employee with 1 year and longer), limited-term employee (limited-term employee shorter than 1year).

EHE was estimated using the following formula: EHE = monthly household expenditure/square root of the number of household members.

  23 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

2.  Measurement of competence: reliability and validity of the TMIG Index of Competence.

Authors:  W Koyano; H Shibata; K Nakazato; H Haga; Y Suyama
Journal:  Arch Gerontol Geriatr       Date:  1991 Sep-Oct       Impact factor: 3.250

3.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

4.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

Authors: 
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

5.  Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.

Authors:  Atsushi Satoh; Hisatomi Arima; Takayoshi Ohkubo; Nobuo Nishi; Nagako Okuda; Ryusuke Ae; Mariko Inoue; Shuji Kurita; Keiko Murakami; Aya Kadota; Akira Fujiyoshi; Kiyomi Sakata; Tomonori Okamura; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Hypertens       Date:  2017-02       Impact factor: 4.844

Review 6.  Cardiovascular disease and risk factors in Asia: a selected review.

Authors:  Hirotsugu Ueshima; Akira Sekikawa; Katsuyuki Miura; Tanvir Chowdhury Turin; Naoyuki Takashima; Yoshikuni Kita; Makoto Watanabe; Aya Kadota; Nagako Okuda; Takashi Kadowaki; Yasuyuki Nakamura; Tomonori Okamura
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

7.  Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese -- Nippon data 80.

Authors:  Minoru Lida; Kazuo Ueda; Akira Okayama; Kazunori Kodama; Koryo Sawai; Shiego Shibata; Shigemichi Tanaka; Teine Keijnkai; Hiroshi Horibe; Masumi Minowa; Hiroshi Yanagawa; Tsutomu Hashimoto
Journal:  J Hum Hypertens       Date:  2003-12       Impact factor: 3.012

8.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

9.  Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015.

Authors:  Shuhei Nomura; Haruka Sakamoto; Scott Glenn; Yusuke Tsugawa; Sarah K Abe; Md M Rahman; Jonathan C Brown; Satoshi Ezoe; Christina Fitzmaurice; Tsuyoshi Inokuchi; Nicholas J Kassebaum; Norito Kawakami; Yosuke Kita; Naoki Kondo; Stephen S Lim; Satoshi Maruyama; Hiroaki Miyata; Meghan D Mooney; Mohsen Naghavi; Tomoko Onoda; Erika Ota; Yuji Otake; Gregory A Roth; Eiko Saito; Takahiro Tabuchi; Yohsuke Takasaki; Tadayuki Tanimura; Manami Uechi; Theo Vos; Haidong Wang; Manami Inoue; Christopher J L Murray; Kenji Shibuya
Journal:  Lancet       Date:  2017-07-19       Impact factor: 79.321

10.  Revised system to evaluate measurement of blood chemistry data from the Japanese National Health and Nutrition Survey and Prefectural Health and Nutrition Surveys.

Authors:  Masakazu Nakamura; Masahiko Kiyama; Akihiko Kitamura; Yoshinori Ishikawa; Shinichi Sato; Hiroyuki Noda; Nobuo Yoshiike
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211

View more
  5 in total

1.  Association between socioeconomic status and prolonged television viewing time in a general Japanese population: NIPPON DATA2010.

Authors:  Yuka Sumimoto; Masahiko Yanagita; Naomi Miyamatsu; Nagako Okuda; Nobuo Nishi; Yosikazu Nakamura; Koshi Nakamura; Naoko Miyagawa; Motohiko Miyachi; Aya Kadota; Takayoshi Ohkubo; Tomonori Okamura; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  Environ Health Prev Med       Date:  2021-05-07       Impact factor: 3.674

2.  Dietary Inflammatory Index Positively Associated With High-Sensitivity C-Reactive Protein Level in Japanese From NIPPON DATA2010.

Authors:  Yunqing Yang; Atsushi Hozawa; Mana Kogure; Akira Narita; Takumi Hirata; Tomohiro Nakamura; Naho Tsuchiya; Naoki Nakaya; Toshiharu Ninomiya; Nagako Okuda; Aya Kadota; Takayoshi Ohkubo; Tomonori Okamura; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Epidemiol       Date:  2019-02-09       Impact factor: 3.211

3.  Relationship between Kidney Function and Subclinical Atherosclerosis Progression Evaluated by Coronary Artery Calcification.

Authors:  Namuun Ganbaatar; Aya Kadota; Takashi Hisamatsu; Shin-Ichi Araki; Shinji Kume; Akira Fujiyoshi; Sayaka Kadowaki; Sayuki Torii; Keiko Kondo; Hiroyoshi Segawa; Ebtehal Salman; Itsuko Miyazawa; Takashi Yamamoto; Yoshihisa Nakagawa; Hiroshi Maegawa; Katsuyuki Miura; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2021-10-22       Impact factor: 4.394

4.  Randomized Controlled Trial of Simple Salt Reduction Instructions by Physician for Patients with Type 2 Diabetes Consuming Excessive Salt.

Authors:  Chikako Oyabu; Emi Ushigome; Yuriko Ono; Ayaka Kobayashi; Yoshitaka Hashimoto; Ryosuke Sakai; Hiroya Iwase; Hiroshi Okada; Isao Yokota; Toru Tanaka; Michiaki Fukui
Journal:  Int J Environ Res Public Health       Date:  2021-06-28       Impact factor: 3.390

5.  Electrocardiographic Left Atrial Abnormality and B-Type Natriuretic Peptide in a General Japanese Population: NIPPON DATA2010.

Authors:  Satoshi Shoji; Shun Kohsaka; Mitsuaki Sawano; Tomonori Okamura; Aya Hirata; Daisuke Sugiyama; Takayoshi Ohkubo; Yasuyuki Nakamura; Makoto Watanabe; Aya Kadota; Hirotsugu Ueshima; Akira Okayama; Katsuyuki Miura
Journal:  J Atheroscler Thromb       Date:  2020-03-19       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.